Isis Pharmaceuticals gaps up in pre-market, levels to watch 11/09 09:11 AM
The stock is up over 6% in the pre-market. Earlier today, Cowen upgraded the stock to Outperform based on valuation and the firm's optimism surrounding its antisense platform and pipeline. Resistance is at $8.55, the 10-day moving average. Support is at $8.15.